Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Fragasso

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Reviews in Cardiovascular Medicine|July 30, 2024
The Concept of "Heart Failure with Preserved Ejection Fraction": Time for a Critical ReappraisalGabriele Fragasso
Expert Opinion on Therapeutic Targets|August 29, 2022
Aortic valve stenosis: drivers of disease progression and drug targets for therapeutic opportunitiesGiuseppe Pinto, Gabriele Fragasso
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology|November 17, 2012
The light of inflammation in the darkness of the coronary slow flow phenomenonGabriele Fragasso, Francesco Maranta
Journal of Visual Communication in Medicine|April 8, 2024
The origin of the popular iconic heart symbol: fiction or facts?Gabriele Fragasso, Mauro Carlino
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 19, 2007
Reply to 'Differential diagnoses and extracardiac manifestations in left ventricular noncompaction'Altin Palloshi, Gabriele Fragasso
Indian Heart Journal|June 27, 2017
Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertensionRoberto Spoladore, Francesco Maranta, Gabriele Fragasso
The American Journal of Cardiology|August 6, 2008
Heart rate reduction is probably not the main beneficial mechanism by which beta blockade improves outcome in patients with systolic chronic heart failureGabriele Fragasso, Anna Salerno, Alberto Margonato
Journal of the American College of Cardiology|May 30, 2009
Different metabolic effects of selective and nonselective beta-blockers rather than mere heart rate reduction may be the mechanisms by which beta-blockade prevents cardiovascular eventsGabriele Fragasso, Michela Cera, Alberto Margonato
Advances in Experimental Medicine and Biology|November 20, 2016
Pathophysiological Mechanisms and Correlates of Therapeutic Pharmacological Interventions in Essential Arterial HypertensionFrancesco Maranta, Roberto Spoladore, Gabriele Fragasso
Circulation|May 30, 2007
Letter by Fragasso et al regarding article by Tuunanen et al, "Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure"Gabriele Fragasso, Altin Palloshi, Gianluca Perseghin
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Reviews in Cardiovascular Medicine|July 30, 2024
The Concept of "Heart Failure with Preserved Ejection Fraction": Time for a Critical ReappraisalGabriele Fragasso
Expert Opinion on Therapeutic Targets|August 29, 2022
Aortic valve stenosis: drivers of disease progression and drug targets for therapeutic opportunitiesGiuseppe Pinto, Gabriele Fragasso
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology|November 17, 2012
The light of inflammation in the darkness of the coronary slow flow phenomenonGabriele Fragasso, Francesco Maranta
Journal of Visual Communication in Medicine|April 8, 2024
The origin of the popular iconic heart symbol: fiction or facts?Gabriele Fragasso, Mauro Carlino
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 19, 2007
Reply to 'Differential diagnoses and extracardiac manifestations in left ventricular noncompaction'Altin Palloshi, Gabriele Fragasso
Indian Heart Journal|June 27, 2017
Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertensionRoberto Spoladore, Francesco Maranta, Gabriele Fragasso
The American Journal of Cardiology|August 6, 2008
Heart rate reduction is probably not the main beneficial mechanism by which beta blockade improves outcome in patients with systolic chronic heart failureGabriele Fragasso, Anna Salerno, Alberto Margonato
Journal of the American College of Cardiology|May 30, 2009
Different metabolic effects of selective and nonselective beta-blockers rather than mere heart rate reduction may be the mechanisms by which beta-blockade prevents cardiovascular eventsGabriele Fragasso, Michela Cera, Alberto Margonato
Advances in Experimental Medicine and Biology|November 20, 2016
Pathophysiological Mechanisms and Correlates of Therapeutic Pharmacological Interventions in Essential Arterial HypertensionFrancesco Maranta, Roberto Spoladore, Gabriele Fragasso
Circulation|May 30, 2007
Letter by Fragasso et al regarding article by Tuunanen et al, "Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure"Gabriele Fragasso, Altin Palloshi, Gianluca Perseghin
Pageof 12